Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ BAY 598
Click to view available options
Quantity:
5 mg
Description
BAY 598 is a potent and selective competitive inhibitor of SMYD2 lysine methyltransferase (IC50 values are 27 and 58 nM for biochemical and cellular activity assays, respectively), which displays >100-fold selectivity for SMYD2 over a panel of 32 other methyltransferases including SMYD3, SUV420H1, and SUV420H2. BAY 598 enhances apoptotic responses to doxorubicin (Cat. No. 2252) in cancer cell lines, and decreases p53K370me levels in HEK293 cells. It also reduces methylation in tumor cells in a mouse xenograft model.
To request the negative control for BAY 598, please fill out the BAY 369 request form on the SGC website.
Specifications
Specifications
Chemical Name or Material | N-[(4 S)-1-[(Cyanoamino)[[3-(difluoromethoxy)phenyl]imino]methyl]-3-(3,4-dichlorophenyl)-4,5-dihydro-1 H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide |
CAS | 1906919-67-2 |
Quantity | 5 mg |
Target | Additional Lysine Methyltransferase Compounds |
Molecular Formula | C22H20Cl2F2N6O3 |
Formula Weight | 525.34 |
Purity | 98% |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction